TKD Amyloidosis School 2026 (Amiloidoz Okulu)

    Dates:
    Organizer:
    Turkish Society of Cardiology (Türk Kardiyoloji Derneği)
    Location:
    Point Hotel Barbaros, İstanbul, Türkiye
    Specialty:
    Cardiology
    Format:
    In-Person

    The TKD Amyloidosis School (Amiloidoz Okulu) is a two-day educational meeting of the Turkish Society of Cardiology (Türk Kardiyoloji Derneği, TKD), organised jointly by its Cardiac Imaging Working Group and Heart Failure Working Group. It takes place on Saturday 21 and Sunday 22 November 2026 at Point Hotel Barbaros in İstanbul, Türkiye. The course is taught in Turkish and focuses on recognising,

    TKD Amyloidosis School 2026 (Amiloidoz Okulu)

    TKD Amyloidosis School 2026 (Amiloidoz Okulu)1 / 1

    1 photo · tap to enlarge

    TKD Amyloidosis School 2026 (Amiloidoz Okulu)

    Listed 18 Nov 2026

    About this event

    The TKD Amyloidosis School (Amiloidoz Okulu) is a two-day educational meeting of the Turkish Society of Cardiology (Türk Kardiyoloji Derneği, TKD), organised jointly by its Cardiac Imaging Working Group and Heart Failure Working Group. It takes place on Saturday 21 and Sunday 22 November 2026 at Point Hotel Barbaros in İstanbul, Türkiye. The course is taught in Turkish and focuses on recognising, diagnosing and managing cardiac amyloidosis, a condition that is increasingly identified in everyday cardiology practice.

    Programme

    The official pocket programme (PDF) opens on Saturday at 12:30 with a session on the history of cardiac amyloidosis from global and Turkish perspectives (Ertuğrul Okuyan and Stefano Perlini), followed by a satellite symposium on ATTR cardiomyopathy and tafamidis. Case-based sessions walk step by step through diagnosis with echocardiography (Ahmet Barutçu) and cardiac MRI (İbrahim Altun), and show how ATTR-CM is picked up in heart failure clinics (Selda Murat), arrhythmia clinics (Serdar Kuyumcu) and the invasive laboratory (Mert Evlice). The afternoon covers the multidisciplinary approach (İnci Tuğçe Çöllüoğlu), nuclear medicine imaging and AL versus ATTR differentiation (Elgin Özkan), neurological assessment (Arman Çakar), genetics (Filiz Özen), haematological work-up to exclude AL amyloidosis (Tayfun Elibol) and nephrology (Rezzan Eren Sadioğlu).

    Sunday begins at 09:00 with the diagnostic pathway between amyloid types, including a mutant amyloidosis case and family screening, the differential diagnosis of hypertrophic cardiomyopathy (Özge Özden Kayhan) and case-based distinctions between Fabry disease and amyloidosis, followed by treatment-focused sessions.

    Faculty

    Session chairs include Ahmet Çelik, Fahriye Vatansever Ağca, Özge Özden Kayhan, Hakkı Kaya, Menekşe Gerede Uludağ, Yüksel Çavuşoğlu, Serdar Küçükoğlu and Omaç Tüfekçioğlu, with international speaker Stefano Perlini.

    Who should attend

    Cardiologists, cardiology residents, imaging specialists and heart failure teams, together with haematologists, neurologists, nephrologists and geneticists involved in amyloidosis care.

    Registration and accreditation

    The organiser has not published fees or CME/CPD credits on its website, so none are shown here. Please contact the Turkish Society of Cardiology (tkd.org.tr) for registration; CME Gallery does not take bookings. The programme includes industry-supported satellite sessions, which are labelled as such in the official programme.

    Ratings & Reviews

    No ratings yet
    Nov 21 – Nov 22, 2026
    Istanbul · Point Hotel Barbaros, İstanbul, Türkiye
    Turkish
    FREE WEEKLY DIGEST

    Never miss a CME event

    Get curated events for your specialty — every week